CN Patent

CN101653607B — 含有肝细胞生长因子受体抑制剂和丝裂原细胞外激酶抑制剂的药物组合物及其用途

Assigned to Dinkum International Investment Hong Kong Co ltd · Expires 2013-02-13 · 13y expired

What this patent protects

本发明涉及一种含有肝细胞生长因子受体(cMet)抑制剂与丝裂原细胞外激酶(MEK)抑制剂的药物组合物及其在制备治疗肝癌、肺癌、胃癌、肠癌、脑瘤、胰腺癌、卵巢癌、乳腺癌或前列腺癌的药物中的应用，本发明药物组合物具有显著的协同效应，提高了药物的疗效，降低了给药剂量，减少了副作用的发生。

USPTO Abstract

本发明涉及一种含有肝细胞生长因子受体(cMet)抑制剂与丝裂原细胞外激酶(MEK)抑制剂的药物组合物及其在制备治疗肝癌、肺癌、胃癌、肠癌、脑瘤、胰腺癌、卵巢癌、乳腺癌或前列腺癌的药物中的应用，本发明药物组合物具有显著的协同效应，提高了药物的疗效，降低了给药剂量，减少了副作用的发生。

Drugs covered by this patent

Patent Metadata

Patent number
CN101653607B
Jurisdiction
CN
Classification
—
Expires
2013-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Dinkum International Investment Hong Kong Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.